In addition, it is clear that in many dystroglycanopathies, overexpression of LARGE can lead to reintroduction of glycosylation motifs required for ECM binding, even in diseases where LARGE is the not the mutated gene22. Here, LARGE1 is linked to neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan.